Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Apr;109(4):391–397. doi: 10.1289/ehp.01109391

Mixtures of four organochlorines enhance human breast cancer cell proliferation.

J Payne 1, M Scholze 1, A Kortenkamp 1
PMCID: PMC1240280  PMID: 11335188

Abstract

In view of the large differences between the concentrations of estrogenic chemicals needed to elicit effects in in vitro assays and their levels in human tissues, it is hard to explain possible health risks in terms of exposure to individual compounds. Human populations, however, are exposed to mixtures of estrogenic and estrogen-like agents and it is necessary to consider the impact of combined effects. We assessed the combined effects of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane (o,p'-DDT), 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene (p,p'-DDE), beta-hexachlorocyclohexane (beta-HCH), and 1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane (p,p'-DDT) on the induction of cell proliferation in MCF-7 cells. All four compounds are persistent organochlorines that can be found in human tissues. We performed extensive concentration-response analyses with the single agents to predict the effects of two mixtures of all four compounds with different mixture ratios. We calculated the predictions by using the pharmacologically well-founded models of concentration addition and independent action and then tested them experimentally. o,p'-DDT, p,p'-DDE, beta-HCH, and p,p'-DDT acted together to produce proliferative effects in MCF-7 cells. The combined effect of the four agents could be predicted on the basis of data about single agent concentration-response relationships. Regression analysis demonstrated that there were combination effects even when each mixture component was present at levels at or below its individual no-observed-effect-concentration. We assessed combination effects in two ways: First, evaluations in relation to the proliferative responses induced by single mixture components revealed that the combination effects were stronger than the effects of the most potent constituent. Thus, according to this method of evaluation, the combined effects may be termed synergistic. Second, comparisons with the expected effects, as predicted by concentration addition and independent action, showed excellent agreement between prediction and observation. With this approach, the combined effect of all four compounds can be termed additive.

Full Text

The Full Text of this article is available as a PDF (109.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARIENS E. J., SIMONIS A. M., VAN ROSSUM J. M. A theoretical basis of molecular pharmacology; II. Interactions of one or two compounds with two interdependent receptor systems. Arzneimittelforschung. 1956 Oct;6(10):611–621. [PubMed] [Google Scholar]
  2. Andersen H. R., Andersson A. M., Arnold S. F., Autrup H., Barfoed M., Beresford N. A., Bjerregaard P., Christiansen L. B., Gissel B., Hummel R. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect. 1999 Feb;107 (Suppl 1):89–108. doi: 10.1289/ehp.99107s189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnold S. F., Klotz D. M., Collins B. M., Vonier P. M., Guillette L. J., Jr, McLachlan J. A. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science. 1996 Jun 7;272(5267):1489–1492. doi: 10.1126/science.272.5267.1489. [DOI] [PubMed] [Google Scholar]
  4. Arnold S. F., Vonier P. M., Collins B. M., Klotz D. M., Guillette L. J., Jr, McLachlan J. A. In vitro synergistic interaction of alligator and human estrogen receptors with combinations of environmental chemicals. Environ Health Perspect. 1997 Apr;105 (Suppl 3):615–618. doi: 10.1289/ehp.97105s3615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ashby J., Lefevre P. A., Odum J., Harris C. A., Routledge E. J., Sumpter J. P. Synergy between synthetic oestrogens? Nature. 1997 Feb 6;385(6616):494–494. doi: 10.1038/385494a0. [DOI] [PubMed] [Google Scholar]
  6. Berenbaum M. C. The expected effect of a combination of agents: the general solution. J Theor Biol. 1985 Jun 7;114(3):413–431. doi: 10.1016/s0022-5193(85)80176-4. [DOI] [PubMed] [Google Scholar]
  7. Berenbaum M. C. What is synergy? Pharmacol Rev. 1989 Jun;41(2):93–141. [PubMed] [Google Scholar]
  8. Berrino F., Muti P., Micheli A., Bolelli G., Krogh V., Sciajno R., Pisani P., Panico S., Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996 Mar 6;88(5):291–296. doi: 10.1093/jnci/88.5.291. [DOI] [PubMed] [Google Scholar]
  9. Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2496–2500. doi: 10.1073/pnas.83.8.2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bustos S., Denegri J. C., Diaz F., Tchernitchin A. N. p,p'-DDT is an estrogenic compound. Bull Environ Contam Toxicol. 1988 Oct;41(4):496–501. doi: 10.1007/BF02020992. [DOI] [PubMed] [Google Scholar]
  11. Chou T. C., Talalay P. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem. 1981 Mar 16;115(1):207–216. doi: 10.1111/j.1432-1033.1981.tb06218.x. [DOI] [PubMed] [Google Scholar]
  12. Davidson N. E., Yager J. D. Pesticides and breast cancer: fact or fad? J Natl Cancer Inst. 1997 Dec 3;89(23):1743–1744. doi: 10.1093/jnci/89.23.1743. [DOI] [PubMed] [Google Scholar]
  13. Davis D. L., Bradlow H. L., Wolff M., Woodruff T., Hoel D. G., Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect. 1993 Oct;101(5):372–377. doi: 10.1289/ehp.93101372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dewailly E., Ayotte P., Brisson J., Dodin S. Breast cancer and organochlorines. Lancet. 1994 Dec 17;344(8938):1707–1708. [PubMed] [Google Scholar]
  15. Dorgan J. F., Longcope C., Stephenson H. E., Jr, Falk R. T., Miller R., Franz C., Kahle L., Campbell W. S., Tangrea J. A., Schatzkin A. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):533–539. [PubMed] [Google Scholar]
  16. Fürst P., Fürst C., Wilmers K. Human milk as a bioindicator for body burden of PCDDs, PCDFs, organochlorine pesticides, and PCBs. Environ Health Perspect. 1994 Jan;102 (Suppl 1):187–193. doi: 10.1289/ehp.102-1566908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hunter D. J., Hankinson S. E., Laden F., Colditz G. A., Manson J. E., Willett W. C., Speizer F. E., Wolff M. S. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med. 1997 Oct 30;337(18):1253–1258. doi: 10.1056/NEJM199710303371801. [DOI] [PubMed] [Google Scholar]
  18. Kelce W. R., Stone C. R., Laws S. C., Gray L. E., Kemppainen J. A., Wilson E. M. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature. 1995 Jun 15;375(6532):581–585. doi: 10.1038/375581a0. [DOI] [PubMed] [Google Scholar]
  19. Kortenkamp A., Altenburger R. Approaches to assessing combination effects of oestrogenic environmental pollutants. Sci Total Environ. 1999 Aug 15;233(1-3):131–140. doi: 10.1016/s0048-9697(99)00228-4. [DOI] [PubMed] [Google Scholar]
  20. Kortenkamp A., Altenburger R. Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles. Sci Total Environ. 1998 Sep 29;221(1):59–73. doi: 10.1016/s0048-9697(98)00261-7. [DOI] [PubMed] [Google Scholar]
  21. Krieger N., Wolff M. S., Hiatt R. A., Rivera M., Vogelman J., Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst. 1994 Apr 20;86(8):589–599. doi: 10.1093/jnci/86.8.589. [DOI] [PubMed] [Google Scholar]
  22. Könemann H. Fish toxicity tests with mixtures of more than two chemicals: a proposal for a quantitative approach and experimental results. Toxicology. 1981;19(3):229–238. doi: 10.1016/0300-483x(81)90132-3. [DOI] [PubMed] [Google Scholar]
  23. López-Carrillo L., Blair A., López-Cervantes M., Cebrián M., Rueda C., Reyes R., Mohar A., Bravo J. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res. 1997 Sep 1;57(17):3728–3732. [PubMed] [Google Scholar]
  24. McLachlan J. A. Synergistic effect of environmental estrogens: report withdrawn. Science. 1997 Jul 25;277(5325):462–463. doi: 10.1126/science.277.5325.459d. [DOI] [PubMed] [Google Scholar]
  25. Payne J., Jones C., Lakhani S., Kortenkamp A. Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Sci Total Environ. 2000 Mar 29;248(1):51–62. doi: 10.1016/s0048-9697(99)00479-9. [DOI] [PubMed] [Google Scholar]
  26. Ramamoorthy K., Wang F., Chen I. C., Norris J. D., McDonnell D. P., Leonard L. S., Gaido K. W., Bocchinfuso W. P., Korach K. S., Safe S. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology. 1997 Apr;138(4):1520–1527. doi: 10.1210/endo.138.4.5056. [DOI] [PubMed] [Google Scholar]
  27. Reiter L. W., DeRosa C., Kavlock R. J., Lucier G., Mac M. J., Melillo J., Melnick R. L., Sinks T., Walton B. T. The U.S. federal framework for research on endocrine disruptors and an analysis of research programs supported during fiscal year 1996. Environ Health Perspect. 1998 Mar;106(3):105–113. doi: 10.1289/ehp.98106105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Scholze M., Boedeker W., Faust M., Backhaus T., Altenburger R., Grimme L. H. A general best-fit method for concentration-response curves and the estimation of low-effect concentrations. Environ Toxicol Chem. 2001 Feb;20(2):448–457. [PubMed] [Google Scholar]
  29. Shekhar P. V., Werdell J., Basrur V. S. Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines. J Natl Cancer Inst. 1997 Dec 3;89(23):1774–1782. doi: 10.1093/jnci/89.23.1774. [DOI] [PubMed] [Google Scholar]
  30. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., Boyd M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990 Jul 4;82(13):1107–1112. doi: 10.1093/jnci/82.13.1107. [DOI] [PubMed] [Google Scholar]
  31. Soto A. M., Chung K. L., Sonnenschein C. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect. 1994 Apr;102(4):380–383. doi: 10.1289/ehp.94102380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Soto A. M., Sonnenschein C., Chung K. L., Fernandez M. F., Olea N., Serrano F. O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995 Oct;103 (Suppl 7):113–122. doi: 10.1289/ehp.95103s7113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Steinmetz R., Young P. C., Caperell-Grant A., Gize E. A., Madhukar B. V., Ben-Jonathan N., Bigsby R. M. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Res. 1996 Dec 1;56(23):5403–5409. [PubMed] [Google Scholar]
  34. Sumpter J. P., Jobling S. Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ Health Perspect. 1995 Oct;103 (Suppl 7):173–178. doi: 10.1289/ehp.95103s7173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Toniolo P. G., Levitz M., Zeleniuch-Jacquotte A., Banerjee S., Koenig K. L., Shore R. E., Strax P., Pasternack B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995 Feb 1;87(3):190–197. doi: 10.1093/jnci/87.3.190. [DOI] [PubMed] [Google Scholar]
  36. Toppari J., Larsen J. C., Christiansen P., Giwercman A., Grandjean P., Guillette L. J., Jr, Jégou B., Jensen T. K., Jouannet P., Keiding N. Male reproductive health and environmental xenoestrogens. Environ Health Perspect. 1996 Aug;104 (Suppl 4):741–803. doi: 10.1289/ehp.96104s4741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vonier P. M., Crain D. A., McLachlan J. A., Guillette L. J., Jr, Arnold S. F. Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator. Environ Health Perspect. 1996 Dec;104(12):1318–1322. doi: 10.1289/ehp.961041318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zava D. T., Blen M., Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect. 1997 Apr;105 (Suppl 3):637–645. doi: 10.1289/ehp.97105s3637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van't Veer P., Lobbezoo I. E., Martín-Moreno J. M., Guallar E., Gómez-Aracena J., Kardinaal A. F., Kohlmeier L., Martin B. C., Strain J. J., Thamm M. DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. BMJ. 1997 Jul 12;315(7100):81–85. doi: 10.1136/bmj.315.7100.81. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES